Download now Free registration required
In order for CBI to make strategic go-forward decisions on its Neural Matrix Chip technology, Mr. Chinn and his colleagues required critical research relating to its intellectual property development, competitors and possible future uses for the technology itself. Make the wrong decision, and the company ran the risk of patent infringement and the end of its pursuit for the ultimate medical breakthrough - restoring a person's ability to walk, see and function normally. To meet these challenges, CBI turned to Nerac Analyst Richard Hendriks, Ph.D. Dr. Hendriks' research regarding possible patent infringement scenarios as well as his customized assessment of CBI's IP landscape has helped the Company's executives make safer, more reliable decisions regarding possible future applications for its Neural Network Matrix device.
- Format: PDF
- Size: 0 KB